ISPOR Europe 2025 highlighted that patient voice drives #HTA, value, and access. PROs, COAs, preference evidence, real-world data, and #JCA all matter — integrate early for stronger, decision-ready submissions. Read more: ow.ly/9XnQ50XFTuS

ow.ly/y4I550XuUw1 EU Joint Clinical Assessments are reshaping orphan drug access in Europe.
Download RTI Health Solutions’ free report for the key challenges, evidence needs, and strategies to stay ahead.

#OrphanDrugs #RareDisease #JCA

We're excited to announce that we've expanded our collaboration with Bekhealth and Innovo Research to set a new standard for how EHR data is transformed into actionable intelligence for clinical research and RWE. -> ow.ly/kqFm50Xo1mB #drugdevelopment #HealthOutcomes 🧪 PharmSky Medsky

What happens when you need clear, expert-driven guidance on when and how a therapy should be used in clinical practice? We used a Delphi panel approach—bringing together expert consensus to inform treatment guidelines. See the case study -> ow.ly/e09o50WxrFb 🧪 PharmSky Medsky #medaffairs

ow.ly/AksJ50WYfNS
🚀 Pharma innovation doesn’t end at approval—it begins with adoption. Why do some breakthrough therapies struggle to gain traction in the real world? Our latest whitepaper explores how Implementation Science can bridge the gap.
🧪 PharmSky Medsky

Smarter pharma research starts with responsible AI. RTI Health Solutions is leading the way with:
✅ Validated Artificial Intelligence tools
✅ Human oversight
✅ Global compliance
Let’s innovate with integrity.🔗Learn more about our approach at ow.ly/sN4550WXs2c #PharmaInnovation 🧪 PharmSky Medsky

Developing an ultra-rare disease therapy? Identifying a suitable comparator for pricing and reimbursement can be a big hurdle. Here's how we helped a client navigate complex global market access challenges with a strategic roadmap for regional value dossiers. ow.ly/NsNB50WxspH 🧪 PharmSky Medsky

What a week at #ISPEAnnual2025 in DC!
From powerful sessions to meaningful connections, we left inspired.
💡 Check out the research we presented and follow-up with our team at ow.ly/V8Ee50WRx0R

Are you leveraging Implementation Science in your Pharma or MedTech research? This proactive, evidence-based model helps anticipate and overcome barriers to adoption—accelerating the integration of innovative therapies into clinical practice. Download the whitepaper at go.rti.org/LeverageImpSci

The TARGET Guideline for target trial emulation is now publicly available. This new guideline will improve reporting transparency of studies using real-world data to emulate a pragmatic randomized trial and improve clarity, completeness, and credibility of findings. Learn more at ow.ly/vLpa50WPPHr

🧬 A biopharmaceutical company needed to validate its health economic model for a rare disease across healthcare systems. See how RTI Health Solutions helped them navigate regional complexities and ensure their model stood up to scrutiny. ow.ly/t9ek50WxrwX Pharma Strategy, Value Assessment

The recording is here! If you missed our webinar on unlocking the full potential of literature reviews in your pharmaceutical or health technology asset development, you can watch it here-> ow.ly/i9Cn50V63Lm #pharmaceutical #healthtechnology #litreviews

If you are working on health research studies with UK data, who is accessing, managing, and interpreting that data for you? Our researchers can determine whether CPRD data may be the best option for your research questions. ow.ly/fpc750UR4oT #realworldevidence #realworlddata 🧪PharmSky